Back

GeroScience

22 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Linking Modifiable Risk Factors to Vascular and Neurodegenerative Brain Changes
2026-03-02 geriatric medicine 10.64898/2026.02.28.26347178
#1 (6.9%)
Show abstract

INTRODUCTIONDementia reflects vascular and neurodegenerative processes in late life, yet studies often examine risks and outcomes individually. This study tested whether the cumulative burden of risks relates to structural brain pathology and cognition, and whether brain markers mediate these associations. METHODSCross-sectional data were drawn from 38,414 older adults in the National Alzheimers Coordinating Center database. A composite score summed ten binary risk factors: hypertension, diabet...

2
Study protocol for FAXAge: A randomized, controlled clinical trial of fasting and exercise to slow aging in humans
2026-03-02 geriatric medicine 10.64898/2026.02.28.26347327
#1 (6.8%)
Show abstract

Biomarkers of aging, particularly DNA methylation-based clocks, have shown promise as tools to assess whether interventions may impact the rate of biological aging. Among possible interventions physical exercise has shown protective effects against many age-associated diseases, while time-restricted feeding (TRF), has shown metabolic benefits in preclinical models. The combined effect of exercise and TRF on aging biomarkers remains largely unexplored. In this 52-week four-armed, randomized, cont...

3
High-dose accelerated intermittent theta burst stimulation improves cognitive function in early Alzheimer's disease: A randomized sham-controlled trial
2026-02-16 geriatric medicine 10.64898/2026.02.13.26346250
Top 0.1% (6.1%)
Show abstract

IntroductionThis clinical trial investigates the efficacy and safety of a personalized 15-day accelerated intermittent theta-burst stimulation (aiTBS) protocol, targeted at either the default mode network (DMN) or the fronto-parietal network (FPN), in individuals with mild Alzheimers disease (AD). Methods45 patients with mild AD were randomized 1:1:1 to receive 15 consecutive days of high-dose aiTBS (7200 pulses/day) targeting the DMN or FPN, or sham. The primary outcome was the change in ADAS-...

4
Development of a Multi-Trait Polygenic Score for Intrinsic Capacity
2026-02-27 geriatric medicine 10.64898/2026.02.25.26347054
Top 0.2% (6.0%)
Show abstract

BackgroundIntrinsic capacity (IC) is a key marker of healthy ageing, which captures an individuals physical and mental capacities, measured across five domains: cognitive, locomotor, psychological, vitality, and sensory. Although genetic factors are known to influence both general IC and its individual domains, existing IC indices have been developed primarily using phenotypic data, without accounting for the underlying biological architecture across domains. In this study, we developed a multi-...

5
Vestibular Perceptual Thresholds, Balance Impairment, and Fall Risk in Community-Dwelling Older Adults
2026-02-25 geriatric medicine 10.64898/2026.02.19.26346653
Top 0.2% (5.6%)
Show abstract

BackgroundVestibular complaints are common in older adults and are linked to imbalance and falls. Some older adults show impaired vestibular perception despite preserved peripheral-reflex ("vestibular agnosia"). Yet it remains unclear if vestibular agnosia is independently linked to imbalance and falls in otherwise healthy older adults. We therefore investigated the prevalence of vestibular agnosia in community-dwelling older adults, and examined its association to balance and prospective falls....

6
Circulating Senescence Protein Links Exercise Adaptation to Health Outcomes
2026-02-12 geriatric medicine 10.64898/2026.02.09.26345899
Top 0.2% (5.4%)
Show abstract

Adaptation to physiological stress is fundamental to health but varies widely among individuals. In humans, this heterogeneity is evident in markedly different gains in fitness in response to identical exercise training. The molecular determinants of this variable "trainability" remain poorly understood. Here we identify insulin-like growth factor binding protein-7 (IGFBP7), a senescence-associated secreted protein, as a circulating constraint on exercise adaptation. Plasma proteomics in older a...

7
Do Perspectives Matter? Comparing Patient, Informant, and Clinician Subjective Cognitive Decline
2026-02-16 geriatric medicine 10.64898/2026.02.13.26346246
Top 0.2% (5.4%)
Show abstract

Structured AbstractO_ST_ABSBACKGROUNDC_ST_ABSPatient reports are the standard when examining subjective cognitive decline (SCD). Recent research suggests that informant and clinician reports may also be associated with cognition. This study examined differences between patient, informant, and clinician definitions of SCD and their relationship to cognition. METHODSData from 4290 older adults (n=1690 normal controls, NC; n=840 mild cognitive impairment, MCI; n=1760 Alzheimers disease, AD) were e...

8
Dissociating the Nocturnal Physiological Drivers of Agitation Occurrence and Severity in Dementia: An Explanatory Study Using Contactless Sleep Sensing
2026-03-02 geriatric medicine 10.64898/2026.02.27.26346707
Top 0.2% (5.2%)
Show abstract

INTRODUCTIONAgitation is a common and burdensome neuropsychiatric symptom in dementia that fluctuates from day to day, but objective tools for short-term risk stratification are limited. We examined whether nocturnal physiological signals from unobtrusive under-mattress sensors predict next-day daytime agitation and whether associations differ for agitation occurrence versus severity. METHODSWe extracted cardiorespiratory, movement, and sleep-proxy features from two long-term care cohorts (N=55...

9
Walking in the Free World: Establishing Normative Trajectories for Ecological Assessment of Robust Gait Variability with Age
2026-03-06 geriatric medicine 10.64898/2026.03.06.26347806
Top 0.3% (5.0%)
Show abstract

Gait variability is a critical functional indicator of dynamic balance and neurocognitive decline in health. Its translation into clinical practice is, however, challenged by a lack of age-related normative trajectories and reference values under real-world ecological settings. Furthermore, the conventional metrics used to estimate gait variability (Coefficient of Variation, CV; Standard Deviation, SD) have a fundamental methodological flaw: the inherent sensitivity of conventional metrics to th...

10
Disentangling physiological heterogeneity in retinal aging using a deep learning-based biological age framework
2026-02-16 health informatics 10.64898/2026.02.13.26346265
Top 0.4% (3.9%)
Show abstract

Biological age estimators quantify aging-related variation but provide limited insight into organ-specific aging processes. The retina enables non-invasive visualization of microvascular and neural structures and has emerged as a promising modality for biological age prediction. However, existing retinal aging models typically produce unidimensional age estimates with limited interpretability. Here we develop a deep learning framework based on a large-scale vision foundation model to estimate re...

11
Comprehensive Evaluation of Associations between Lifestyle Factors and Multiple Epigenetic Aging Indicators in the Japanese Population: A cross-sectional study
2026-02-09 epidemiology 10.64898/2026.02.07.26345813
Top 0.4% (3.7%)
Show abstract

BackgroundEpigenetic clocks based on DNA methylation (DNAm) provide quantitative indicators of biological aging. However, the extent to which diverse lifestyle factors influence DNAm-based aging measures remains unclear, especially in Japanese populations. We aimed to evaluate the associations between 52 lifestyle-related factors and multiple epigenetic aging indicators, including six DNAm ages (Horvath, Hannum, PhenoAge, GrimAge, GrimAge v2, and PCPhenoAge specific to Japanese Population), the ...

12
Are low ergothioneine levels a risk factor for age-related macular degeneration and other ocular disorders?
2026-03-02 ophthalmology 10.64898/2026.02.27.26347162
Top 0.5% (2.8%)
Show abstract

Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in ageing populations, with oxidative stress recognised as a key pathogenic driver. The dietary antioxidant and cytoprotectant, L-ergothioneine (ET), is avidly accumulated in many tissues, especially the eye. However its relationship to AMD has not been investigated. Here, we examined ETs distribution in ocular tissue and assessed circulating and intraocular ET levels in patients with neovascular AMD. Compared...

13
Ability to Detect Changes and Minimal Important Difference of Real-World Digital Mobility Outcomes in Proximal Femoral Fracture Patients
2026-03-06 geriatric medicine 10.64898/2026.03.06.26347770
Top 0.5% (2.2%)
Show abstract

Background Older adults' walking has so far been evaluated using standardised assessments of walking capacity within a clinical setting. By taking the evaluation out of the laboratory into the real world, this study provides first evidence of the ability of Digital Mobility Outcomes (DMOs) to detect changes over time and the Minimal Important Difference (MID) in patients after proximal femoral fracture (PFF). This will guide the implementation of DMOs in research and clinical care. Methods For t...

14
Multimodal latent composites are associated with cognition and Alzheimer's disease dementia: a framework for systems-level brain health
2026-02-23 neurology 10.64898/2026.02.21.26346745
Top 0.7% (1.9%)
Show abstract

Biomarkers from diverse methodological domains are increasingly important in the detection, diagnosis and tracking of neurological diseases and brain health, yet they are often evaluated in isolation. Statistical integration approaches, such as factor analysis, provide a means to combine complementary biomarkers and capture higher-order domains of brain health. Exploratory factor analysis has previously been employed to identify latent brain health constructs using multimodal MRI, fluid biomarke...

15
Reproducible metabolomic fingerprinting strengthens postmortem evaluation of insulin intoxication
2026-03-02 toxicology 10.64898/2026.02.27.26347264
Top 0.7% (1.9%)
Show abstract

BackgroundFatal insulin intoxication remains difficult to diagnose because insulin undergoes rapid degradation after death, limiting the reliability of direct biochemical measurements. This creates diagnostic uncertainty when objective molecular confirmation of insulin excess are required. We hypothesised that insulin excess induces systemic metabolic alterations that persist beyond insulin degradation and can be captured using postmortem metabolomics in a forensic setting. MethodsHigh-resoluti...

16
Early life blood pressure, cognitive function and brain aging in mid-to-late life: A synthetic longitudinal cohort analysis
2026-02-26 epidemiology 10.64898/2026.02.24.26346790
Top 0.8% (1.8%)
Show abstract

PURPOSEOver 6.9 million Americans above the age of 65 are living with Alzheimers Disease (AD) or related dementias (ADRDs), which are diseases characterized by cognitive decline and structural brain changes associated with accelerated brain aging. Cardiovascular risk factors, in particular hypertension, are well-studied risk factors for AD/ARD. Evidence suggests that the effects of hypertension on cognitive aging may vary by life stage, yet prior studies have focused on the effects of mid- or la...

17
Metabolic Adaptations to Long-Term Caloric Restriction: Principal Components Analysis of Mass-Spectrometry Metabolomics from the CALERIE™ Phase 2 Trial
2026-02-24 nutrition 10.64898/2026.02.20.26346654
Top 0.9% (1.6%)
Show abstract

BackgroundCaloric restriction (CR) improves markers of biological aging, yet long-term effects on the human metabolome remain unclear. ObjectiveThis study examined the effects of CR (2 years) in healthy adults without obesity on circulating metabolites linked to aging and metabolic adaptations. MethodsUntargeted metabolomics was performed using fasted plasma samples collected at baseline, 12, and 24 months (BL, 12M, 24M) from CALERIE participants randomized to CR or ad libitum (AL) control. A ...

18
Treatment Effects of Cholinesterase Inhibitors in Alzheimer's Disease: a Causal Machine Learning Approach
2026-02-12 pharmacology and therapeutics 10.64898/2026.02.11.26346078
Top 0.9% (1.5%)
Show abstract

AO_SCPLOWBSTRACTC_SCPLOWO_ST_ABSINTRODUCTIONC_ST_ABSTreatment response in Alzheimers disease (AD) varies substantially across patients, yet no validated frameworks exist to estimate heterogeneous treatment effects (HTE) from observational data while controlling for confounding bias. METHODSWe developed a causal machine learning framework integrating expert-guided causal graphs, complementary HTE estimators, sensitivity analyses, and policy learning. We applied it to cholinesterase inhibitors (C...

19
Clinical validation of automated and multiple manual callosal angle measurement methods in idiopathic normal pressure hydrocephalus
2026-02-14 radiology and imaging 10.64898/2026.02.12.26346185
Top 1% (1.4%)
Show abstract

IntroductionIdiopathic normal pressure hydrocephalus (iNPH) is a partially reversible neurological disorder in which imaging biomarkers support diagnosis and surgical decision-making. The callosal angle (CA) is one of the most robust radiological markers of iNPH and has also been associated with postoperative shunt outcome. However, several manual measurement variants exist and artificial intelligence (AI)-based tools now enable automatic CA measurement. Materials and MethodsIn total 71 patient...

20
Enhancing Prediabetes Diagnosis from Continuous Glucose Monitoring Data via Iterative Label Cleaning and Deep Learning
2026-03-05 health informatics 10.64898/2026.03.04.26347604
Top 1% (1.4%)
Show abstract

As of early 2026, over 115 million US adults (more than 1 in 3) have prediabetes, a condition with an annual conversion rate of 5%-10% to type 2 diabetes. Total diabetes (diagnosed and undiagnosed) affects approximately 40.1 million Americans, or 12% of the population, with roughly 1.5 million new cases diagnosed annually. Continuous Glucose Monitoring (CGM) provides real-time, 24/7 insights into glycemic variability, detecting dangerous highs, lows, and trends that HbA1c (a 3-month average) mis...